ClinicalTrials.Veeva

Menu

Inflammation Markers in Fluid Aspirate From a Scarred Uterine vs. a Normal Uterine Cavity

H

Hadassah Medical Center

Status

Enrolling

Conditions

Infertility Due to Nonimplantation
Cesarean Section Complications
Infertility Secondary

Treatments

Diagnostic Test: Uterine lavage

Study type

Interventional

Funder types

Other

Identifiers

NCT06322498
INFLAM.UTERUS-HMO-CTIL

Details and patient eligibility

About

A prospective study that will take place in the hydrosonography clinic, comparing patients with an intact uterus to those who had a caesarean section. Eligible patients will preform a transvaginal ultrasound for evaluation of presence of a niche. After fixation of the transcervical catheter, we will flush 2 ml sterile NaCl 0.9% into the uterine cavity and aspirate the fluid. After collecting all samples, the samples will be snap frozen and stored at -80o C, until they undergo an immunological analysis.

Enrollment

100 estimated patients

Sex

Female

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients suffering from infertility and assigned for a hydrosonography exam for assessment of the integrity of the uterus and fallopian tubes.

Exclusion criteria

  1. Patients with hydrosalpinx/pyosalpinx/sactosalpinx
  2. Patients who went through surgical correction of a niche
  3. Hormonal treatment- estrogens or progestins.
  4. Immunosuppressive/immunomodulating medication

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Intact uterus
Experimental group
Description:
Patients with intact uterus
Treatment:
Diagnostic Test: Uterine lavage
Scarred uterus
Experimental group
Description:
Patients with scarred uterus
Treatment:
Diagnostic Test: Uterine lavage

Trial contacts and locations

1

Loading...

Central trial contact

Chana Adler, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems